Stock Alerts: Co-Diagnostics Sees Aggressive US Expansion On New FDA Policy

Shares of Co-Diagnostics, Inc. (CODX) are up more than 60% and trading at $14.66 in early hours, after the company said that a new FDA policy released last night to expedite the availability of COVID-19 diagnostics, will allow it to aggressively expand its presence in the U.S. market.

from RTT - Before the Bell https://ift.tt/33nIzQp
via IFTTT